spacer
home > pmps > summer 2018 > rethinking processes
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Rethinking Processes

Managing regulatory compliance has always been a challenge for organisations, particularly those in the pharmaceutical space. Stakes are even higher today as companies must balance adherence to strict, often exhaustive, and continuously changing policies and procedures with the desire to embrace digital transformation and accelerate business to keep up with growing global competition.

This leaves the regulatory affairs, as well as quality and compliance personnel, in the middle, serving as the conduit between standards bodies or agencies, and senior leadership representing manufacturing, supply chain, and other key operational functions. The back-and-forth can be dizzying as one side expects compliance at all costs and the other desires getting product to customers faster and more efficiently than ever.

Labelling is one such area that crosses departmental boundaries. For manufacturing and supply chain, the barcode label is the passport that enables the fast identification, transport, tracking, and delivery of product from production line to endcustomer. For the regulatory manager, that same label must conform to a myriad of regulations and standards, many of which are a moving target due to constant change.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Laura Johnson at Loftware brings over 20 years of expertise working with both pharma and medical device manufacturers to improve processes and meet regulatory requirements such as serialisation, UDI, and secure supply chain. Laura’s career has also focussed on the application of technology to drive efficiencies in manufacturing, warehousing, and distribution environments. She is experienced in leveraging core functionality within major ERP systems and implementing automatic data capture technologies such as vision inspection, printing, shop floor devices, barcode, and radio-frequency identification data collection.
spacer
Laura Johnson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Regulatory bottlenecks mean EU clinicians and patients could lose access to medical devices under new rules

European clinicians and their patients could lose access to vital medical devices, including in-vitro diagnostics, due to a lack of agencies able to certify products in time to comply with strict new regulations.
More info >>

White Papers

Recommendations for Implementing Assessment Criteria Guidelines in Lymphoma and Chronic Lymphocytic Leukemia Clinical Trials

Perceptive Informatics

Standardized assessment criteria are becoming increasingly important in obtaining valid outcomes in oncology clinical trials. While standardized criteria encourage a more uniform approach to assessing clinical trial data, they are often subject to the interpretation of the user. These differences in interpretation, while seemingly minor, can have a major impact on assessments. The most commonly used standardized criteria for lymphoma have been no exception. Differences such as minimum new lesion size, lymph node normalization size requirements, inclusion of extranodal lesions and assessment of organomegaly can have a profound effect on overall response. Additionally, heightened scrutiny of the assessment criteria used in a given protocol can lead to questions about a drug’s efficacy if not applied correctly according to regulators’ interpretation.
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement